Ancora Advisors, LLC Cti Biopharma Corp Transaction History

Ancora Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$1.9 - $5.23 $1 - $5	1 New	1 $0
Q3 2021 Nov 15, 2021	SELL	$2.25 - $3.18 $2 - $3	-1 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.72 - $1.64 $0 - $1	1 New	1 $0
Q4 2018 Feb 15, 2019	SELL	$0.73 - $2.19 $0 - $2	-1 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$1.72 - $5.24 $1 - $5	1 New	1 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.